Estelamari Rodriguez, MD, MPH, is the associate director of community outreach for thoracic oncology and the assistant ...
The once-daily oral drug improves patients’ lives while maintaining early, durable, and central nervous system responses, ...
Bridging therapy was administered to 90% of apheresed patients, with chemotherapy ± radiotherapy used in 53% and targeted ...
FDA approval establishes setmelanotide as the first labeled option for acquired hypothalamic obesity, addressing a population ...
Maria Hordinsky, MD, discusses exciting results in alopecia areata, including some discussed at the Winter Clinical ...
Accelerated approval of semaglutide 7.2 mg establishes a higher-dose, once-weekly GLP-1 RA option for long-term weight ...
In this episode, ‘Assessing Clinical and Economic Factors in Treatment Selection and Payer Decision-Making,’ the panelists ...
Across treatment classes, CH associated with increased therapy-related cytopenias, particularly neutropenia, and DNMT3A/TET2 ...
Survival in myeloma is clearly being prolonged,” says Mikhael. “Whereas historically, we saw a greater impact in younger ...
Pulmonary expert Noah Greenspan, DPT, discusses long COVID, early pandemic uncertainty, and how vaccination may help reduce ...
NHANES 2017–2018 elastography data (n=4102) linked to mortality showed 59 deaths over ~24 months; decedents were older and more likely to have diabetes. MASLD (CAP ≥274 dB/m) with diabetes carried ...
This episode, titled Optimizing Subcutaneous Therapies in NSCLC: Practical Integration, Patient Selection, and Workflow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results